Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of approximately RMB2.492 billion for the first three quarters, down 24.73% year on year.
Baiyunshan (00874) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB62.076 billion, up 0.76% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.492 billion, down 24.73% year on year; and basic earnings per share of RMB1.533.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB62.076 billion, up 0.76% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.492 billion, down 24.73% year on year; and basic earnings per share of RMB1.533.
Related Articles
US Stock Market Move | Cryptocurrency trading revenue plunges 55% year-over-year; Robinhood (HOOD.US) falls over 4% in early trading.
.png)
Stock price soars nearly 15%! Activist investor Peltz plans to take Wendy's (WEN.US) private for US$1.4 billion.
US Stock Market Move | Genmab (GMAB.US) surged nearly 26% intraday, with its stock price hitting an all-time high.
US Stock Market Move | Cryptocurrency trading revenue plunges 55% year-over-year; Robinhood (HOOD.US) falls over 4% in early trading.
Stock price soars nearly 15%! Activist investor Peltz plans to take Wendy's (WEN.US) private for US$1.4 billion.
US Stock Market Move | Genmab (GMAB.US) surged nearly 26% intraday, with its stock price hitting an all-time high.
